Humana Inc. will release financial results for the first quarter 2025 (1Q25) and host a live question-and-answer session on Wednesday, April 30, 2025. Additionally, the company will host an Investor ...
Zacks Investment Research on MSN9hOpinion
3 HMO Stocks to Watch Amid Nurse Shortages, High Tech Costs
The U.S. health insurance industry, referred to as Health Maintenance Organization (HMO), is aided by membership growth on ...
For the first time in 15 years, employment across the major health insurance companies fell last year, according to a Modern Healthcare analysis.
With large opportunities in its target markets, management aims to continue growing at a fast pace with a long-term annual earnings per share growth goal of 11%-15%. While Humana appears focused ...
The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P ...
The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...
Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 ...
In a report released today, Bruce Jackson from Benchmark Co. reiterated a Buy rating on Humacyte (HUMA – Research Report), with a price target ...
The equity portion of the abrdn World Healthcare Fund fell (gross) but outperformed its custom benchmark over Q4 2024. Click ...
Humana’s shares (currently trading at $268.69) have posted a disappointing 15.2% loss while the S&P 500 was down 1.4%. This ...